Optimal management of bone metastases in breast cancer patients

MH Wong, N Pavlakis - Breast Cancer: Targets and Therapy, 2011 - Taylor & Francis
Bone metastasis in breast cancer is a significant clinical problem. It not only indicates
incurable disease with a guarded prognosis, but is also associated with skeletal-related …

Radiopharmaceuticals for metastatic bone pain palliation: available options in the clinical domain and their comparisons

T Das, S Banerjee - Clinical & experimental metastasis, 2017 - Springer
Bone pain arising due to skeletal metastases is one of the common complications
experienced by the majority of patients suffering from prostate, breast and lung cancer at the …

Evaluation of charged particle induced reaction cross section data for production of the important therapeutic radionuclide 186Re

M Hussain, S Sudár, MN Aslam, AA Malik… - Radiochimica …, 2010 - degruyter.com
Abstract 186Re is an important radionuclide having a half-life of 3.72 d that is suitable for
radioimmunotherapy. Its production in no-carrier-added form is done via charged particle …

Biology of bone metastases: causes and consequences

HA Harvey, L von Reyn Cream - Clinical breast cancer, 2007 - Elsevier
Breast cancer is a highly osteotropic neoplasm, and as many as 75% of patients with
metastatic disease will have involvement of the bony skeleton. On radiologic examination …

Blood–brain barrier disruption in dementia: Nano‐solutions as new treatment options

CG Cooper, KN Kafetzis, A Patabendige… - European Journal of …, 2024 - Wiley Online Library
Candidate drugs targeting the central nervous system (CNS) demonstrate extremely low
clinical success rates, with more than 98% of potential treatments being discontinued due to …

Isotopes of strontium: Properties and applications

VS Semenishchev, AV Voronina - Strontium Contamination in the …, 2020 - Springer
The chapter gives an overview of properties and application of stable and radioactive
isotopes of strontium. Natural strontium consists of the following four stable isotopes: 84 Sr …

177Lu-EDTMP for Metastatic Bone Pain Palliation: A Systematic Review and Meta-Analysis

E Askari, S Harsini, N Vahidfar, G Divband… - Cancer biotherapy & …, 2021 - liebertpub.com
Purpose: Painful metastatic bone involvement is common in advanced stages of many
cancers. Between available radionuclides for bone pain palliation, no consensus has been …

Improving the dose–myelotoxicity correlation in radiometabolic therapy of bone metastases with 153Sm-EDTMP

M Pacilio, G Ventroni, C Basile, P Ialongo… - European journal of …, 2014 - Springer
Purpose 153 Sm-ethylene diamine tetramethylene phosphonic acid (153 Sm-EDTMP) is
widely used to palliate pain from bone metastases, and is being studied for combination …

Targeted radionuclide therapy of painful bone metastases: past developments, current status, recent advances and future directions

A Dash, T Das, FFR Knapp - Current medicinal chemistry, 2020 - ingentaconnect.com
Bone pain arising from secondary skeletal malignancy constitutes one of the most common
types of chronic pain among patients with cancer which can lead to rapid deterioration of the …

Theranostics–present and future

L Królicki, J Kunikowska - Bio-Algorithms and Med-Systems, 2022 - degruyter.com
Theragnostics in nuclear medicine constitute an essential element of precision medicine.
This notion integrates radionuclide diagnostics procedures and radionuclide therapies using …